BrainChip, Shares

BrainChip Shares Plunge to Fresh Low Following Index Removal

Published on 03/23/2026 at 05:56 | Redaktion boerse-global.de

BrainChip shares plummet to new annual low following index exclusion, triggering automated selling. Despite 374% revenue growth, the AI chip firm faces steep losses and market skepticism.

BrainChip Shares Plunge to Fresh Low Following Index Removal Illustration mit AI erstellt übermittelt durch boerse-global.de
BrainChip Shares Plunge to Fresh Low Following Index Removal Illustration mit AI erstellt übermittelt durch boerse-global.de

Monday proved to be a pivotal and challenging session for BrainChip Holdings Ltd. The semiconductor specialist's stock plummeted to a new annual low, pressured by its official removal from the S&P/ASX 300 index. This technical development triggered automated selling, overshadowing management's continued focus on advancing its core technology.

Automated Selling Intensifies Market Pressure

Exclusion from the prominent Australian benchmark forced numerous institutional funds to divest their holdings, creating significant automated sell-side pressure. This wave of selling converged with an already fragile market sentiment surrounding the AI chip developer. The equity touched a new low of €0.08 during the session, cementing a year-to-date decline of approximately 20%. From a chart perspective, the situation remains tenuous, with the stock trading substantially below its 200-day moving average.

Market skepticism was echoed earlier by analysts at Peak Asset Management, who issued a sell recommendation in mid-March. Industry experts point to the overwhelming market dominance of giants like Nvidia as a primary headwind. For smaller players in the artificial intelligence hardware sector, capturing meaningful market share against established competitors is becoming increasingly difficult.

Operational Progress Amid Persistent Losses

Despite the severe share price weakness, BrainChip has demonstrated notable operational growth, although it continues to grapple with substantial losses. The financial figures for the 2025 fiscal year highlight this contrast:

Should investors sell immediately? Or is it worth buying BrainChip?

  • 2025 Revenue: USD 1.89 million (a 374% increase)
  • Operating Loss: USD 21.71 million
  • Net Loss: USD 20.47 million
  • Cash & Equivalents: USD 31.7 million

The company's liquidity position was recently bolstered by a successful institutional placement. These proceeds are being channeled primarily into the development of its next-generation neuromorphic processor, the AKD2500. In collaboration with its partner ASICLAND, BrainChip is working to finalize a silicon prototype.

The anticipated technological milestone is scheduled for the third quarter of 2026, contingent on the prototype's timely completion. The company's strategy hinges on leveraging its technology's ultra-low power consumption to target niche markets. Applications in defense, healthcare, and intelligent edge-based sensor systems are key focus areas, where BrainChip believes it holds a decisive advantage over more computationally intensive cloud solutions.

Ad

BrainChip Stock: New Analysis - 23 March

Fresh BrainChip information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BrainChip analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | AU000000BRN8 | BRAINCHIP | boerse | 68964132 |